These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36997873)

  • 21. Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis.
    Ward T; Glaser A; Johnsen A; Xu F; Hall I; Pellis L
    BMJ Open; 2021 Nov; 11(11):e056636. PubMed ID: 34819293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
    Aruffo E; Yuan P; Tan Y; Gatov E; Moyles I; Bélair J; Watmough J; Collier S; Arino J; Zhu H
    BMC Public Health; 2022 Jul; 22(1):1349. PubMed ID: 35841012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of Non-pharmaceutical Interventions on COVID-19 Mortality: A Generalized Synthetic Control Approach Across 169 Countries.
    Mader S; Rüttenauer T
    Front Public Health; 2022; 10():820642. PubMed ID: 35444988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-pharmaceutical interventions in containing COVID-19 pandemic after the roll-out of coronavirus vaccines: a systematic review.
    He X; Chen H; Zhu X; Gao W
    BMC Public Health; 2024 Jun; 24(1):1524. PubMed ID: 38844867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis.
    Summan A; Nandi A
    Eur J Health Econ; 2022 Feb; 23(1):105-117. PubMed ID: 34304325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non Pharmaceutical Interventions for Optimal Control of COVID-19.
    Zamir M; Shah Z; Nadeem F; Memood A; Alrabaiah H; Kumam P
    Comput Methods Programs Biomed; 2020 Nov; 196():105642. PubMed ID: 32688137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of non-pharmaceutical interventions on COVID-19 cases in South Australia and Victoria.
    Milazzo A; Giles L; Parent N; McCarthy S; Laurence C
    Aust N Z J Public Health; 2022 Aug; 46(4):482-487. PubMed ID: 35557482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study interrupted time-series analysis.
    Maglietta G; Puntoni M; Caminiti C; Pession A; Lanari M; Caramelli F; Marchetti F; De Fanti A; Iughetti L; Biasucci G; Suppiej A; Miceli A; Ghizzi C; Vergine G; Aricò M; Stella M; Esposito S;
    Front Public Health; 2024; 12():1393677. PubMed ID: 38699417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022).
    Willem L; Abrams S; Franco N; Coletti P; Libin PJK; Wambua J; Couvreur S; André E; Wenseleers T; Mao Z; Torneri A; Faes C; Beutels P; Hens N
    BMC Public Health; 2024 Apr; 24(1):1171. PubMed ID: 38671366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.
    ÓhAiseadha C; Quinn GA; Connolly R; Wilson A; Connolly M; Soon W; Hynds P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    Coudeville L; Jollivet O; Mahé C; Chaves S; Gomez GB
    PLoS One; 2021; 16(4):e0250797. PubMed ID: 33909687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of vaccinations, boosters and lockdowns on COVID-19 waves in French Polynesia.
    Chapman LAC; Aubry M; Maset N; Russell TW; Knock ES; Lees JA; Mallet HP; Cao-Lormeau VM; Kucharski AJ
    Nat Commun; 2023 Nov; 14(1):7330. PubMed ID: 37957160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting the complex time-varying effect of non-pharmaceutical interventions on COVID-19 transmission in the United States.
    Wu G; Zhang W; Wu W; Wang P; Huang Z; Wu Y; Li J; Zhang W; Du Z; Hao Y
    Front Public Health; 2024; 12():1343950. PubMed ID: 38450145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Non-pharmaceutical Interventions on the Control of COVID-19 in Iran: A Mathematical Modeling Study.
    Nakhaeizadeh M; Eybpoosh S; Jahani Y; Ahmadi Gohari M; Haghdoost AA; White L; Sharifi H
    Int J Health Policy Manag; 2022 Aug; 11(8):1472-1481. PubMed ID: 34273920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.
    Giardina J; Bilinski A; Fitzpatrick MC; Kendall EA; Linas BP; Salomon J; Ciaranello AL
    JAMA Netw Open; 2022 Feb; 5(2):e2147827. PubMed ID: 35157056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study.
    Galmiche S; Cortier T; Charmet T; Schaeffer L; Chény O; von Platen C; Lévy A; Martin S; Omar F; David C; Mailles A; Carrat F; Cauchemez S; Fontanet A
    Lancet Microbe; 2023 Jun; 4(6):e409-e417. PubMed ID: 37084751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea.
    Lee S; Lee DW; Kim JM; Kim DW; Kim JY; Kim JA; Kim IH; Rhee JE; Min KD; Cho SI; Kim EJ; Kwon JH
    Emerg Microbes Infect; 2023 Dec; 12(2):2228934. PubMed ID: 37345516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations.
    Head JR; Andrejko KL; Remais JV
    medRxiv; 2021 Aug; ():. PubMed ID: 34462757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.